Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI   US84763A1088

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
6.21(c) 6.13(c) 5.97(c) 5.95(c) 6.005(c) Last
916 404 1 045 938 1 931 136 1 186 875 705 709 Volume
+0.65% -1.29% -2.61% -0.34% +0.92% Change
More quotes
Financials ($)
Sales 2015 162 M
EBIT 2015 -35,5 M
Net income 2015 -38,3 M
Debt 2015 -
Yield 2015 -
Sales 2016 162 M
EBIT 2016 -38,0 M
Net income 2016 -32,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 2,47x
Capi. / Sales 2016 2,49x
Capitalization 402 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. is a biotechnology company with fully integrated commercial and drug development operations, with a primary focus in hematology and oncology.It operates through one segment: acquiring, developing and commercializing prescription drug products.The company markets two... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
03/25 SPECTRUM PHARMACEUTICALS : Reports Robust Clinical Data and Strong 2014 Financia..
03/23 SPECTRUM PHARMACEUTICALS : Technical Pulse on Biotech Stocks -- Geron, Lexicon P..
03/13 SPECTRUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
03/13 SPECTRUM PHARMACEUTICALS : Pharma reports 4Q loss
03/13 SPECTRUM PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
03/13 SPECTRUM PHARMACEUTICALS : Reports Robust Clinical Data and Strong 2014 Financia..
03/12 SPECTRUM PHARMACEUTICALS : Reports Robust Clinical Data and Strong 2014 Financia..
03/11 SPECTRUM PHARMACEUTICALS : Four Oncology Key Opinion Leaders to Present at Spect..
More news
Sector news : Biotechnology & Medical Research - NEC
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/13 SEEKING ALPHA'S BIOTECH WEEKLY : Deeper Looks At Orexigen, Pharmacyclics, And Ac..
03/13 Spectrum Pharmaceuticals (SPPI) Q4 2014 Results - Earnings Call Webcast
03/13 Spectrum Pharma non-GAAP Q4 EPS up 80%
03/13 Spectrum Pharmaceuticals beats by $0.11, beats on revenue
03/12 Notable earnings before Friday?s open


Comments 
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF